Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
802 participants
INTERVENTIONAL
2007-10-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glaucoma Adherence Study
NCT00676637
Glaucoma Adherence Study, Spain
NCT00680329
Adherence Assessment With Travalert Dosing Aid
NCT00508469
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00311389
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
NCT00329095
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Use of TravAlert dosing aid with or without drop guider
Each patient will use a dosing aid and/or drop guider for 6 months
2
Use of TravAlert dosing aid with or without drop guider
Each patient will use a dosing aid and/or drop guider for 6 months
3
Use of TravAlert dosing aid with or without drop guider
Each patient will use a dosing aid and/or drop guider for 6 months
4
Use of TravAlert dosing aid with or without drop guider
Each patient will use a dosing aid and/or drop guider for 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of TravAlert dosing aid with or without drop guider
Each patient will use a dosing aid and/or drop guider for 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treatment with travoprost or travoprost/timolol
Exclusion Criteria
* Absolute inability to administer eye drops
* Difficulty in reading or speaking Dutch
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Ophthalmology, University Hospital Maastricht
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helena J Beckers, MD/phD
Role: PRINCIPAL_INVESTIGATOR
Maastricht University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jeroen Bosch ziekenhuis
's-Hertogenbosch, , Netherlands
Medisch centrum Alkmaar
Alkmaar, , Netherlands
Wilhelmina ziekenhuis
Assen, , Netherlands
Amphia ziekenhuis
Breda, , Netherlands
Deventer ziekenhuis
Deventer, , Netherlands
Catharina ziekenhuis
Eindhoven, , Netherlands
Groene hart ziekenhuis
Gouda, , Netherlands
ziekenhuis de Tjongerschans
Heerenveen, , Netherlands
Atrium medisch centrum
Heerlen, , Netherlands
Westfries gasthuis
Hoorn, , Netherlands
University hospital
Maastricht, , Netherlands
Canisius Wilhelmina ziekenhuis
Nijmegen, , Netherlands
Erasmus medisch centrum
Rotterdam, , Netherlands
Isala klinieken
Zwolle, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTCM-071015
Identifier Type: -
Identifier Source: secondary_id
MEC 07-1-015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.